azacitidine celgene
celgene europe bv - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
abraxane 5 mg/1 ml prašak za suspenziju za infuziju
apomedical d.o.o. - paklitaksel - prašak za suspenziju za infuziju - 5 mg/1 ml - 1 ml suspenzije sadrži: 5 mg paklitaksela
revlimid 2.5mg kapsula, tvrda
"evropa lek pharma" doo podgorica - lenalidomid - kapsula, tvrda - 2.5mg
revlimid 5mg kapsula, tvrda
"evropa lek pharma" doo podgorica - lenalidomid - kapsula, tvrda - 5mg
revlimid 10mg kapsula, tvrda
"evropa lek pharma" doo podgorica - lenalidomid - kapsula, tvrda - 10mg
revlimid 15mg kapsula, tvrda
"evropa lek pharma" doo podgorica - lenalidomid - kapsula, tvrda - 15mg
revlimid 25mg kapsula, tvrda
"evropa lek pharma" doo podgorica - lenalidomid - kapsula, tvrda - 25mg
abraxane 100mg prašak za suspenziju za infuziju
amicus pharma doo podgorica - paklitaksel - prašak za suspenziju za infuziju - 100mg
vidaza 100 mg/1 bočica prašak za suspenziju za injekciju
amicus pharma d.o.o. - azacitidin - prašak za suspenziju za injekciju - 100 mg/1 bočica - 1 bočica sa praškom za suspenziju za injekciju sadrži: 100 mg azacitidina (nakon rekonstitucije svaki ml suspenzije sadrži 25 mg azacitidina)
abraxane 5 mg/1 ml prašak za disperziju za infuziju
amicus pharma d.o.o. - paklitaksel - prašak za disperziju za infuziju - 5 mg/1 ml - 1 ml disperzije sadrži: 5 mg paklitaksela